Xconomy: Raleigh-Durham top stories News, Articles and Opinions

Results for “”

Entry	Author	Date	Location
Second US Gene Therapy, Approved for Rare Muscle Disease, to Cost $2M	Ben Fidler	05/24/19	National
Bio Roundup: Zolgensma Watch, Brain Cancer Blues, Peloton Payout & More	Alex Lash	05/24/19	National
Sebastian Thrun and Udacity Launch New Self-Driving Nanodegree	Bernadette Tansey	05/21/19	San Francisco
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More	Frank Vinluan	05/17/19	National
ASCO Abstracts: Breast Cancer, Precision Treatments in the Spotlight	Ben Fidler	05/16/19	National
Endpoint Security Company CrowdStrike Files Publicly for IPO	Bernadette Tansey	05/14/19	San Francisco
Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More	Ben Fidler	05/10/19	National
Uber Completes $8.1B Public Market Debut in Spite of Tumultuous Past	Bernadette Tansey	05/09/19	San Francisco
Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials	Frank Vinluan	05/09/19	National
SMA, Migraine Data Lead Neuro Highlights from AAN Meeting	Ben Fidler	05/07/19	National
Pendo Adds to Analytics, Engagement Software With Receptive Purchase	David Holley	05/07/19	Raleigh Durham
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More	Alex Lash	05/03/19	National
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments	Frank Vinluan	05/03/19	National
Beyond Meat’s IPO Bags $241M to Make Plant-Based Burgers Mainstream	Frank Vinluan	05/02/19	National
SMA Moment: Will Gene Therapy Shift Treatment, Costs of Muscle Disease?	Ben Fidler	05/02/19	National
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More	Frank Vinluan	04/26/19	National
Join Xconomy for Our 8th Annual Napa Summit, June 13-14	Gregory T. Huang	04/23/19	National
SPECIAL REPORT: 2019 Blockchain Outlook — Reality Check	Jeff Engel	04/23/19	National
Can We Afford to Be Cured? A Conversation With ICER’s Steve Pearson	Alex Lash	04/23/19	Boston
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More	Ben Fidler	04/19/19	National
$100M for Talaris Gives Surgeon a Shot to Reinvent Organ Transplants	Ben Fidler	04/18/19	Boston
Hatteras Launches New Fund With $94M for Life Science Investments	Frank Vinluan	04/15/19	Raleigh Durham
How an Ohio Kids’ Hospital Quietly Became Ground Zero for Gene Therapy	Ben Fidler	04/15/19	National
Lyft, Uber, and the Changing Disclosure Rules For Unicorn IPOs	Bernadette Tansey	04/12/19	San Francisco
Thwarting Opposition, Bristol Gets Shareholder OK for $74B Celgene Buyout	Ben Fidler	04/12/19	New York
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More	Alex Lash	04/12/19	National
AskBio Reels In $235M to Advance Gene Therapy Clinical Trials	Frank Vinluan	04/11/19	Raleigh Durham
Senators Grill Pharmacy Benefit Execs About Skyrocketing Drug Prices	Frank Vinluan	04/09/19	National
Bio Roundup: Gottlieb’s Goodbye, AACR Recap, Migraine Drug Fight & More	Frank Vinluan	04/05/19	National
AACR 2019 Roundup: Notes from a Weekend of Early Stage Cancer Results	Ben Fidler	04/03/19	National
Page 1 of 26	next page »